News from wuxi pharmatech A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 29, 2015, 04:22 ET WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


May 21, 2015, 08:00 ET WuXi Launches e-Commerce Platform for Chemistry Products

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


Apr 30, 2015, 08:00 ET WuXi Biologics Begins Construction of the World's Largest Mammalian Cell Culture Manufacturing Facility Using Disposable Bioreactors

WuXi Biologics, a wholly owned subsidiary of WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform...


Apr 22, 2015, 07:00 ET Big Data and Genomics Meet the Cloud: the First Unified Global Platform for Precision Medicine

SHANGHAI; CAMBRIDGE, Mass.; and MOUNTAIN VIEW, Calif., April 22, 2015 /PRNewswire/ – WuXi PharmaTech (Cayman) Inc. (NYSE: WX), whose leading...


Apr 08, 2015, 08:00 ET Nobel Prize Laureate Professor Barry Sharpless Visits WuXi AppTec Headquarters in Shanghai

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


Apr 02, 2015, 08:30 ET WuXi PharmaTech Lists Shares of Small-Molecule Manufacturing Subsidiary STA on New Third Board in China

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


Mar 05, 2015, 04:30 ET WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2014 Results

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


Feb 27, 2015, 05:04 ET WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


Feb 17, 2015, 08:00 ET WuXi PharmaTech Enters into Syndicated Loan Agreement

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


Feb 06, 2015, 09:25 ET WuXiPRA Appoints Two Key Executives

WuXiPRA, a leading clinical services company with operations in the greater China region, today announced appointments of two key executives. Liedong ...


Jan 30, 2015, 08:00 ET WuXi PharmaTech's Small-Molecule Manufacturing Subsidiary STA Wins CMO Leadership Award

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


Jan 09, 2015, 08:00 ET WuXi PharmaTech Provides Update of 2014 Financial Guidance, to Present at J.P. Morgan Healthcare Conference

WuXi PharmaTech (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and...


Jan 05, 2015, 08:00 ET WuXi PharmaTech Statement on Recent News Report

WuXi PharmaTech stated today that a recent news report regarding purported FDA communication with a company named Novacyl Wuxi Pharmaceutical does...


Dec 08, 2014, 08:00 ET WuXi PharmaTech Presents 2014 Life Science and Chemistry Awards

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


Dec 04, 2014, 04:30 ET WuXi AppTec Wins SCRIP Award for "Best Company in an Emerging Market"

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


Dec 03, 2014, 04:30 ET WuXi PharmaTech Subsidiary Submits Application to the National Equities Exchange and Quotations in China to List on the New Third Board

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


Oct 30, 2014, 08:00 ET WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical,...


Oct 23, 2014, 04:30 ET WuXi Congratulates TaiMed Biologics on Receiving Orphan Drug Designation for Ibalizumab from U.S. FDA

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China...


Sep 30, 2014, 08:00 ET WuXi PharmaTech Announces Appointment of William R. Keller to Board

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China...


Aug 18, 2014, 08:00 ET WuXi Facility Passes FDA Inspection for Manufacture of API

WuXiPharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in ...


Aug 13, 2014, 04:30 ET WuXi PharmaTech Announces Second-Quarter 2014 Results

WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development services company serving the pharmaceutical, biotechnology, and medical...


Aug 08, 2014, 08:00 ET WuXi PharmaTech Announces Appointment of Walter Kwauk to Board

WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China...


Jun 23, 2014, 08:00 ET WuXi AppTec Webinar on Breakthrough Drugs Draws Strong Attendance

More than 400 life science innovators recently tuned in to a global webinar hosted by WuXi AppTec to gain insights into the advancement of programs...


May 23, 2014, 08:00 ET Targos Molecular Pathology GmbH and WuXi PharmaTech to Collaborate in Clinical Biomarker Services and Pathology Training in China

Targos GmbH, a leader in clinical biomarker services, and WuXi PharmaTech (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D...


May 21, 2014, 08:12 ET WuXi PharmaTech Toxicology Facility in Suzhou Passes OECD GLP Inspection

WuXi PharmaTech (NYSE: WX) today announced that its toxicology facility in Suzhou had received a statement of Good Laboratory Practice (GLP) from the ...